Navigation Links
Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
Date:12/7/2007

PT. RICHMOND, Calif., Dec. 7 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, President & Chief Executive Officer, will participate in an expert panel on "Drug Development in a Changed Environment" at the RBC Capital Markets 2007 Healthcare Conference at the Westin New York Hotel at Times Square on Thursday, December 13, 2007 at 10:00 AM Eastern Time.

The multi-company panel will be moderated by Ken Trbovich, Vice President, Capital Markets at RBC, and will be available at the following link via webcast: http://www.wsw.com/webcast/rbc84/panel24.

About Transcept Pharmaceuticals

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs. Transcept development projects leverage new understanding of CNS conditions to provide additional uses and enhanced clinical benefits for existing active agents. The lead Transcept product, Intermezzo(R) (zolpidem tartrate lozenge), is a low dose sublingual formulation of zolpidem that is currently in late phase 3 clinical trials for the treatment of insomnia in patients who awaken in the middle of the night and have difficulty returning to sleep. Another product being developed by Transcept is TO-2060, a novel, fixed-dose combination of olanzapine and ondansetron for the treatment of dopamine associated psychiatric disorders. TO-2060 is currently the subject of an initial proof of concept trial in the treatment of alcohol use disorder. For more information, please visit the company's website at: http://www.transcept.com.

Contacts:

Transcept Pharmaceuticals, Inc. The Ruth Group

Michael Gill Investors / Media

Director of Communications Stephanie Carrington / Jason Rando

(510) 215-3575
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...PHIA, Nov. 21 NursingCenter.com, t...cation and peer reviewed content, has been,update...0,000 registered,users. Powered by Lippincott Wil...provides over 900 peer-reviewed continuing educati...from more than 50 leading nursing journals.,Lippi...
(Date:11/21/2008)... LAKES, N.J., Nov. 21 To...edical intervention in treating 88 percent of pati... of Americans treated for a chronic condition acco...ng and 75 percent of all medical costs. A proprie... by Medco Health Solutions, Inc. (NYSE: MHS ) si...
(Date:11/21/2008)... B.C., a new and deadly diseaseits cause remains a...tate was teeming with citizens, soldiers and refug...ta. As streets filled with corpses, social order b...returned twice and Athens lost a third of its popu...marked the beginning of the end of the Golden Age ...
(Date:11/21/2008)...Ind., Nov. 21 Symmetry M...provider of products to the global orthopedic devi...oday that Brian S. Moore, President and Chief Exec...dent and Chief Financial Officer, are scheduled to...are Conference at The New York Palace Hotel on Wed...
Breaking Medicine News(10 mins):Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...ed by researchers that children who light their pa...ly to become smokers themselves. In addition, aski... the store or light a cigarette for the parent are... to smoke. Rafael Laniado-Laborin, M.D., from San ...
...ts better if specialists in critical care medicine...ins and Pittsburgh University have analysed the ev...s (ICUs). //They have found that patients do much ...or who is a specialist in critical care medicine. ...
... suggest that the presence of proteins linked to i...g men with high blood pressure. Although we know t...e, //it's still the case that not everyone with hy... at Malmo University, Sweden, believe that inflamm...
...ave measurable anomalies in their immune system th...ly believed that stress may impair health, althoug...esearchers at Washington University in the US reve...s a specific effect on immunity. When an inflamma...
Other Medicine News:
(Date:11/19/2008)...ewswire/ -- Posit Science Corporation,researcher,... Neuroscience,Annual Conference in Washington, DC... benefit Baby Boomers. The computerized brain pla...ptive exercises that target auditory and,language...eralized,improvements in cognition by improving s...
(Date:11/19/2008)...wswire/ -- Isogen, a contract development and,man... announced the first,phase launch of its contract...ifically address the process, facility and capacit...n highly-niched, low-volume clinical and,early-st... Companies can invest over $100 million and f...
(Date:11/18/2008)...Newswire-USNewswire/ -- Forty-two leading U. S. sc...tional forum to consider cutting-edge innovations ...al economy from outbreaks of dangerous zoonotic di... Among those innovations: , , , , ...le that detects highly contagious and dangerous zo...
(Date:11/13/2008)... Finds Statins Cut Risk of Heart Attacks, Deaths, ...ardiovascular Disease,is the leading cause of deat...undreds of millions of dollars and causing untold ...is fatal disease - even among those who,weren,t th...millions of people could cut their risk of a,heart...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Isogen Launches Major New Facility to Address Global Biopharma Demand 242 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Seniors Can Be Heartened by New Study on Statins 2Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008 18212 1Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008 18212 2Best Practices in Designing Effective Brand Teams 18207 1Best Practices in Designing Effective Brand Teams 18207 2Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting 1956 1Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting 1956 2Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting 1956 3Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting 1956 4Nature paper describes technique for extracting hierarchical structure of networks 3146 1Nature paper describes technique for extracting hierarchical structure of networks 3146 2
...ay 24, 2007 - Generex Biotechnology Corporation,(N...ell, Director,of Immunobiology at its wholly-owned...,s vaccine development strategy at an,internationa...ing,"Developing New Anti-Infective Agents - Chall...,"http://www.anti-infectives-forum.com">www.anti-i...
...USINESS WIRE)--May 25, 2007 - GTx, Inc., (NASDAQ:,...ase II proof of,concept clinical trial of Ostarine... evaluating ACAPODENE(R) (toremifene citrate) 80,m...drogen,deprivation therapy (ADT) will be presented...an Society of Clinical Oncology being,held June 1 ...
Other Medicine Technology:Generex Biotechnology Vaccine Strategy Presented at International,Conference in London 2Generex Biotechnology Vaccine Strategy Presented at International,Conference in London 3GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3
Irrigating nucleus chopper, 1.5 mm long wedge-shaped, inferior edge with round end, 0.6 mm dual sideports 20 gauge.
Karate phaco chopper, semi-sharp, wedge shaped inferior edge with a pointed tip
Phaco chopper, a combination of a modified microfinger and a pointed "quick chop" tip. For use in the left hand.
Titanium. A reverse action instrument with a paddle tips to provide a solid surface to crack the nucleus. When used in scleral tunnel, the reverse action mechanism allows increased flexibility in pos
Medicine Products: